0 NASDAQ Companies - March 14, 2024Breeze Holdings Acquisition Corp. and TV Ammo, Inc. to Participate in the 36th Annual ROTH ConferenceIRVING, Texas and GARLAND, Texas, March 14, 2024 (GLOBE NEWSWIRE) — Breeze Holdings Acquisition Corp. (Nasdaq: BREZ) (“Breeze Holdings”), a […]Read More
0 NASDAQ Companies - March 14, 2024Second Quarter Fiscal 2024 Preliminary Results and Announcement of Earnings DateNonferrous and Finished Steel Sales Volumes Up Year-over-Year Cost Reduction Target Increased PORTLAND, Ore., March 14, 2024 (GLOBE NEWSWIRE) — […]Read More
0 NASDAQ Companies - March 14, 2024Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), […]Read More
0 NASDAQ Companies - March 14, 2024Montauk Renewables Announces Full Year 2023 ResultsPITTSBURGH, March 14, 2024 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company […]Read More
0 NASDAQ Companies - March 14, 2024Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) — Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the […]Read More
0 NASDAQ Companies - March 14, 2024Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19DALLAS, March 14, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage gene […]Read More
0 NASDAQ Companies - March 14, 2024Rackspace Technology Announces Launch of Exchange Offer Relating to its 3.50% First-Priority Senior Secured Notes due 2028SAN ANTONIO, March 14, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT) (“Rackspace” or the “Company”), a leading end-to-end hybrid, […]Read More
0 NASDAQ Companies - March 14, 2024Madrigal Pharmaceuticals Announces FDA Approval of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Moderate to Advanced Liver FibrosisRezdiffra becomes the first and only medication approved by the FDA for the treatment of NASH (also known as “MASH”) […]Read More
0 NASDAQ Companies - March 14, 2024HeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsSouthlake, TX, March 14, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the […]Read More
0 NASDAQ Companies - March 14, 2024Financial Institutions, Inc. Announces 2024 Annual Meeting DateWARSAW, N.Y., March 14, 2024 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ: FISI) (the “Company”), the parent company of Five […]Read More